Preoperative Dry Lean Body Mass as a Prognostic Factor for Excess Weight Loss After Bariatric Surgery.
MMS-CB
1 other identifier
observational
180
1 country
1
Brief Summary
Bariatric surgery is currently the only method that has proven long-term effectiveness in obesity. Although the benefit of physical activity on weight loss has been demonstrated, no correlation has ever been reported between preoperative lean body mass and postoperative weight loss. Dry lean mass is probably an essential prognostic factor for the effectiveness of bariatric surgery. The main objective of this study is to define a preoperative dry lean body mass threshold as a worst prognostic factor for weight loss one year after bariatric surgery. The management of patients included in this study was modelled on the management usually offered to patients followed for the same pathology in the diabeto-endocrinology department. There are no study-specific examinations that are not part of current practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 4, 2018
CompletedFirst Posted
Study publicly available on registry
June 15, 2018
CompletedStudy Start
First participant enrolled
October 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedDecember 23, 2021
December 1, 2021
3.5 years
June 4, 2018
December 22, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measurement of dry lean mass in pre-operative by impedance measurement
Excess weight loss at M12: ideal weight is defined in relation to height for a BMI of 25.0 kg/m2. Excess weight is the difference between the observed weight and the ideal weight. Excess weight loss is the ratio of weight loss to excess weight.
12 months after bariatric surgery
Study Arms (1)
Bariatric surger
Bariatric surgery and impedance measurement
Interventions
Measurement of dry lean body mass berfore bariatric surgery by impedance measurement.
Eligibility Criteria
Patients presenting (or having presented since 2014) an obesity with a bariatric surgery project and followed by endocrinologist doctors.
You may qualify if:
- BMI ≥ 40 or BMI ≥ 35 kg/m2 and a complication that can be improved after bariatric surgery: cardiovascular disease including hypertension, severe metabolic disorder including type 2 diabetes, sleep apnea syndrome or other severe respiratory disorder, hepatic steatosis, disabling osteoarticular disease.
- Patient requiring bariatric surgery (sleeve-gastrectomy or gastric bypass)
- Patient who has agreed to participate in the study
- Patient with social security coverage.
You may not qualify if:
- Patient with a contraindication to bariatric surgery (cognitive or psychological disorders, severe eating disorders, addiction to alcohol or psychoactive substances, contraindication to general anaesthesia, multiple history of digestive surgery, high risk of undernutrition (progressive cancer, chronic inflammatory bowel disease, cirrhosis, severe renal insufficiency...)
- Pregnant or lactating women
- Minor patient
- Major patient under tutorship, curatorship, or deprived of liberty
- Patient unable to understand protocol and / or give express consent
- Patient not affiliated with a social security system or beneficiary of such a scheme
- Patient participating in an intervention-type clinical research protocol likely to modify the evaluations of this protocol
- adults under the protection of justice
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Departemental Vendée
La Roche-sur-Yon, 85925, France
Study Officials
- STUDY DIRECTOR
Barbara FEIGEL-GUILLER, MD
Centre Hospitalier Départemental Vendée
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 4, 2018
First Posted
June 15, 2018
Study Start
October 15, 2018
Primary Completion
April 1, 2022
Study Completion
September 1, 2022
Last Updated
December 23, 2021
Record last verified: 2021-12